Manipal Health Enterprises IPO allotment likely today: How to check status, GMP, listing date, key details

Investors who applied for the Manipal Health Enterprises IPO are likely to receive clarity on their allotment today, August 3, as the company is expected to finalise the share allocation for its Rs 9,275-crore public issue.

Once the allotment process is completed, applicants can check whether they have been allotted shares through the registrar, KFin Technologies, or via the BSE and NSE websites. The company's shares are scheduled to make their stock market debut on August 5.

Ahead of the listing, the grey market premium (GMP) signals a cautious debut. The IPO is currently trading at a discount of around Rs 5–6 in the grey market, indicating an estimated listing price of about Rs 584 against the upper end of the price band of Rs 590. While the GMP offers a snapshot of market sentiment, investors should remember that the grey market is unofficial and unregulated. It should not be viewed as a guarantee of listing-day performance.


The IPO, which was open for bidding from July 29 to July 31, received an overall subscription of 4.92 times.

Institutional investors led the demand, with the Qualified Institutional Buyers (QIB) portion subscribed 8.25 times. The Non-Institutional Investor (NII) category was subscribed 1.02 times, while the Retail Individual Investor (RII) segment received bids for 93% of the shares reserved for retail investors.

The public issue comprised a fresh issue of 13.56 crore equity shares worth Rs 8,000 crore and an Offer for Sale (OFS) of 2.16 crore shares valued at Rs 1,275.22 crore, taking the total issue size to Rs 9,275.22 crore. The price band was fixed at Rs 560–590 per share.

Kotak Mahindra Capital acted as the book-running lead manager, while KFin Technologies is the registrar to the issue.

How to check Manipal Health Enterprises IPO allotment status

Investors can check their allotment status through any of the following platforms:

1. KFin Technologies (Registrar)

• Visit the KFin Technologies IPO allotment page (https://ipostatus.kfintech.com/)
• Select Manipal Health Enterprises from the drop-down menu.
• Enter your PAN, application number, or DP/Client ID.
• Click Submit to view your allotment status.

2. NSE

• Visit the NSE IPO allotment page. (https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids)
• Select Equity.
• Choose Manipal Health Enterprises from the list.
• Enter your application number and PAN to check the status.

3. BSE

• Visit BSE IPO allotment link: https://www.bseindia.com/investors/appli_check
• Now tick Equity under issue type.
• Choose Manipal Health Enterprises from the dropdown menu.
• Enter your application number or PAN.
• Complete the captcha verification and click Search to view your allotment details.

About Manipal Health Enterprises

Founded in 2010, Manipal Health Enterprises has grown into one of India's largest healthcare providers, operating a network of multi-specialty hospitals, clinics and diagnostic centres. The company offers tertiary and quaternary care across specialties including oncology, cardiology, neurology, orthopaedics, organ transplantation and preventive healthcare.

As of March 31, 2026, the company operated 49 hospitals with 13,037 licensed beds, along with 21 clinics across India. Its workforce exceeds 24,000 employees, including more than 11,000 nurses and 6,300 paramedics.

The hospital chain has expanded steadily through strategic acquisitions, investments in healthcare infrastructure and a growing focus on digital healthcare services.

IPO proceeds and their planned use

The company plans to use Rs 5,378 crore from the fresh issue proceeds to repay debt, strengthening its balance sheet and lowering finance costs.

Additionally, Rs 574 crore will be used to acquire a minority stake in its step-down subsidiary, Sahyadri Hospitals, while the remaining funds will be deployed for general corporate purposes and future growth initiatives.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)